Efficacy and safety of glycopyrronium/formoterol delivered via a dry powder inhaler in patients with moderate to severe chronic obstructive pulmonary disease: Results from a multi-centre, open-label, randomised study.
Lung India : official organ of Indian Chest Society(2022)
摘要
The results demonstrate efficacy and safety of GF-DPI in Indian patients with moderate to severe COPD. Treatment with GF-DPI significantly improved the lung function and quality of life and was well tolerated.
更多查看译文
关键词
Bronchodilator,chronic obstructive pulmonary disease,dry powder inhaler,dual bronchodilation,formoterol,glycopyrronium
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要